• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《蛋白质科学领域的旅行顾问指南:提高对重组蛋白质量认识的建议》

The Trip Adviser guide to the protein science world: a proposal to improve the awareness concerning the quality of recombinant proteins.

作者信息

Lebendiker Mario, Danieli Tsafi, de Marco Ario

机构信息

Department of Biomedical Sciences and Engineering, University of Nova Gorica, Glavni Trg 9, SI-5261 Vipava, Slovenia.

出版信息

BMC Res Notes. 2014 Sep 1;7:585. doi: 10.1186/1756-0500-7-585.

DOI:10.1186/1756-0500-7-585
PMID:25178166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4161829/
Abstract

In many research articles, where protein purification is required for various assays, (protein-protein interactions, activity assays, etc.), we always have access to the final results, but seldom have access to the raw data required for an accurate evaluation of the protein quality. This data is extremely important on one hand to critically evaluate the quality of the proteins used in the described research and, on the other hand, to allow other laboratories to safely use the described procedure in a reproducible manner. We herby propose to include a standardized methodology that can easily be incorporated in research papers. Moreover, this methodology can be utilized as a "quality control" ladder, where the more information given, will lead to a higher ranking of the article. This "quality control" stamp will allow researchers retrieving relevant and useful materials and methods in the field of protein research.

摘要

在许多研究文章中,当各种分析(蛋白质-蛋白质相互作用、活性分析等)需要蛋白质纯化时,我们总是能看到最终结果,但很少能获取准确评估蛋白质质量所需的原始数据。这些数据一方面对于严格评估所描述研究中使用的蛋白质质量极为重要,另一方面能让其他实验室以可重复的方式安全地使用所描述的方法。我们特此提议纳入一种可轻松融入研究论文的标准化方法。此外,这种方法可用作一个“质量控制”阶梯,提供的信息越多,文章的排名就越高。这种“质量控制”标识将使研究人员能够检索蛋白质研究领域相关且有用的材料和方法。

相似文献

1
The Trip Adviser guide to the protein science world: a proposal to improve the awareness concerning the quality of recombinant proteins.《蛋白质科学领域的旅行顾问指南:提高对重组蛋白质量认识的建议》
BMC Res Notes. 2014 Sep 1;7:585. doi: 10.1186/1756-0500-7-585.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
4
Guidelines to reach high-quality purified recombinant proteins.高质量重组蛋白纯化指南。
Appl Microbiol Biotechnol. 2018 Jan;102(1):81-92. doi: 10.1007/s00253-017-8623-8. Epub 2017 Nov 18.
5
Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.OCRA 方法评估上肢生物力学过载风险的科学基础,作为 ISO 生物力学风险因素标准中的首选方法。
Scand J Work Environ Health. 2018 Jul 1;44(4):436-438. doi: 10.5271/sjweh.3746.
6
Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis.可重复性研究实践、健康经济评估中的开放性和透明度:一项横断面比较分析的研究方案。
BMJ Open. 2020 Feb 13;10(2):e034463. doi: 10.1136/bmjopen-2019-034463.
7
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
8
Alternatives to animal experimentation in basic research.基础研究中动物实验的替代方法。
ALTEX. 2004;21 Suppl 1:3-31.
9
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.ISPOR 成本效益研究质量改进良好实践工作组报告。
Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.
10
Rules to be adopted for publishing a scientific paper.发表科学论文应采用的规则。
Ann Ital Chir. 2016;87:1-3.

引用本文的文献

1
Purification and Quality Control of Recombinant Proteins Expressed in Mammalian Cells: A Practical Review.哺乳动物细胞表达的重组蛋白的纯化和质量控制:实用综述。
Methods Mol Biol. 2024;2810:329-353. doi: 10.1007/978-1-0716-3878-1_21.
2
Quality control of protein reagents for the improvement of research data reproducibility.蛋白质试剂的质量控制可提高研究数据的可重复性。
Nat Commun. 2021 May 14;12(1):2795. doi: 10.1038/s41467-021-23167-z.
3
Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs.重组抗体生产发展出多种选择,旨在生产出适合特定应用需求的试剂。
Microb Cell Fact. 2015 Sep 2;14:125. doi: 10.1186/s12934-015-0320-7.
4
Quality assessment and optimization of purified protein samples: why and how?纯化蛋白质样品的质量评估与优化:为何及如何进行?
Microb Cell Fact. 2014 Dec 30;13:180. doi: 10.1186/s12934-014-0180-6.
5
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies.细菌细胞质作为生产基于VHH的功能性亲和试剂和骆驼科IgG样重组抗体的有效细胞区室。
Microb Cell Fact. 2014 Sep 16;13:140. doi: 10.1186/s12934-014-0140-1.

本文引用的文献

1
A sea of standards for omics data: sink or swim?组学数据标准的海洋:沉或浮?
J Am Med Inform Assoc. 2014 Mar-Apr;21(2):200-3. doi: 10.1136/amiajnl-2013-002066. Epub 2013 Sep 27.
2
Drug development: Raise standards for preclinical cancer research.药物研发:提高临床前癌症研究标准。
Nature. 2012 Mar 28;483(7391):531-3. doi: 10.1038/483531a.
3
Toward interoperable bioscience data.迈向可互操作的生物科学数据
Nat Genet. 2012 Jan 27;44(2):121-6. doi: 10.1038/ng.1054.
4
Recombinant protein quality evaluation: proposal for a minimal information standard.重组蛋白质量评估:最低信息标准提案
Stand Genomic Sci. 2011 Nov 30;5(2):195-7. doi: 10.4056/sigs.1834511. Epub 2011 Nov 22.
5
Survey of the 2009 commercial optical biosensor literature.2009 年商业光学生物传感器文献调查。
J Mol Recognit. 2011 Nov-Dec;24(6):892-914. doi: 10.1002/jmr.1138.
6
Believe it or not: how much can we rely on published data on potential drug targets?信不信由你:我们能在多大程度上依赖已发表的关于潜在药物靶点的数据?
Nat Rev Drug Discov. 2011 Aug 31;10(9):712. doi: 10.1038/nrd3439-c1.
7
Meeting Report from the Second "Minimum Information for Biological and Biomedical Investigations" (MIBBI) workshop.第二届“生物与生物医学研究的最小信息”(MIBBI)研讨会会议报告
Stand Genomic Sci. 2010 Dec 25;3(3):259-66. doi: 10.4056/sigs.147362.
8
Reagent validation: an underestimated issue in laboratory practice.试剂验证:实验室实践中一个被低估的问题。
J Mol Recognit. 2011 Jan-Feb;24(1):136. doi: 10.1002/jmr.1060.
9
The FEBS Letters/BioCreative II.5 experiment: making biological information accessible.欧洲生物化学学会联合会快报/生物创意II.5实验:让生物信息可获取。
Nat Biotechnol. 2010 Sep;28(9):897-9. doi: 10.1038/nbt0910-897.
10
A call for BMC Research Notes contributions promoting best practice in data standardization, sharing and publication.呼吁《BMC研究笔记》投稿,推广数据标准化、共享和发表方面的最佳实践。
BMC Res Notes. 2010 Sep 2;3:235. doi: 10.1186/1756-0500-3-235.